Genetic Analysis announces placement of directed share issue of appr. NOK 10 mill, intention to conduct subsequent offering to shareholders, non-binding letter of intent for further investment as well as updated milestones 2023-11-022023-11-02 GA private placement letter of intent milestones
Genetic Analysis: Launch of GA-map® Discovery – A microbiome profiling offering for Research Customers 2023-10-252023-10-24 GA-map new product Discovery launch
New Luminex whitepaper describes how the GA-map® Dysbiosis Test utilizes xMAP® technology for microbiome profiling 2023-10-13
Stay updated and subscribe to GA investor newsletters, financial reports and press releases 2023-09-21